Maine Lung Cancer Coalition (MLCC)
Maine Quality Counts has partnered with the Maine Lung Cancer Coalition (MLCC) to assist the MLCC in developing a statewide education program for clinicians on evidenced-based lung cancer screening and prevention. This includes the development of webinars and online education modules. Quality Counts is also responsible for the development and facilitation of the MLCC Patient and Family Advisory Group, which provides input and feedback on the work of the entire MLCC project.
The Maine Lung Cancer Coalition (MLCC) is a 4-year statewide, multi-institution, multi-disciplinary initiative, begun in August 2016, to improve the prevention, early detection and treatment of lung cancer in Maine. Funded by a $5.6M grant from the Bristol-Myers Squibb Foundation, Maine Cancer Foundation, and Maine Economic Improvement Fund, the MLCC brings together diverse stakeholders across the entire state to work together to reduce suffering and death from lung cancer, with a special focus on vulnerable rural populations with limited access to health care.
The overall aim of the MLCC is to develop the infrastructure and inter-institutional collaboration needed to expand access to evidence-based lung cancer prevention and screening services, and to facilitate earlier and more effective treatment of lung cancer for patients across the state. MLCC partner organizations are working together on several major activities aimed at educating health professionals, patients and community members about lung cancer risk, prevention, and screening. These activities include:
- Establishment of a lung cancer screening Learning Community of healthcare institutions throughout the state, who will meet regularly to share information and best practices.
- Development and dissemination of webinars and online education modules for health care providers (as mentioned above, this is the role of Quality Counts in this project).
- Development and dissemination of educational information to the general public.
- Development and evaluation of innovative strategies to reach high-risk individuals living in rural communities with limited access to health care:
- Community Health Workers (CHWs)
- Telemedicine technology
- Health policy advocacy to promote insurance coverage for lung cancer screening and telemedicine consultations, and to address lung cancer environmental risk factors (e.g., residential radon testing and mitigation).
- Research to understand lung cancer risk factors, incidence, health care utilization, and outcomes in Maine, and patients’ and physicians’ knowledge, attitudes, and behaviors regarding lung cancer prevention and screening.
Together, all of these activities will promote a greater understanding of the problem of lung cancer in Maine, and enable MLCC partners to work together to effectively address this problem in the future.
Maine Lung Cancer Coaltion
For more information about the MLCC and to access previous webinars and online learning modules (as they are developed), please visit the Maine Lung Cancer Coalition Website
Together with the MLCC, Maine Quality Counts has an ongoing Patient and Family Advisory Group that meets quarterly regarding this work. If you would like more information, please email MLCC@mainequalitycounts.org
Next Webinar: April 24, 2018; 12:00 pm- 1:00 pm “Radon and Arsenic in Maine, and the Provider’s Role in Preventing Exposure” with Andrew Smith, SM, ScD and Karyn Butts, MPH. Click Here to Register!
January 30, 2018 MLCC Webinar: “Determining Patient Eligibility for Lung Cancer Screening with Low-Dose CT Scan” with Dr. Akshu Balwan, Dr. John Klemperer and Dr. Neil Korsen
July 17, 2017 MLCC Webinar: Radon: The Leading Environmental Cause of Cancer Mortality in the US presented by Jessica Reed, MSN and Bill Field, MD.
June 13, 2017 MLCC Webinar: Working Together To Reduce Lung Cancer In Maine
Funding for this work is provided by the Maine Cancer Foundation and Bristol-Myers Squibb Foundation.